Skip to content

Equity

BME

Health Sciences Trust

Overview

Loading

Performance

Performance

  • Returns

  YTD 1m 1y 3y 5y 10y
22.26 3.01 22.26 60.22 67.96 277.69
Market Price (%) Market price return represents changes to the fund’s closing market price on its primary exchange and accounts for distributions from the fund.

as of Dec 31, 2019

24.15 2.51 24.15 62.98 56.66 306.62

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.


Returns are shown net of advisory fees paid by the fund and net of the fund’s operating fees and expenses. Investors who purchase shares of the fund through an investment adviser or other financial professional may separately pay a fee to that service provider. Past performance is not indicative of future results.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Net Assets as of Jan 22, 2020 $457,007,549
Managed Assets as of Jan 22, 2020 $457,007,549.03
Share Class launch date Mar 31, 2005
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Health
Lipper Classification Sector Equity Funds
CUSIP 09250W107
Management Fee 1.00%
Gross Expense Ratio 1.11%
Shares Outstanding as of Jan 22, 2020 10,889,079
Number of Holdings as of Dec 31, 2019 104

Ratings

Ratings

Morningstar Rating

Overall Morningstar Rating for Health Sciences Trust, -, as of Dec 31, 2019 rated against 6 Health Funds based on risk adjusted total return.

Holdings

Holdings

as of Dec 31, 2019
Name Weight (%)
UNITEDHEALTH GROUP INC 8.93
ABBOTT LABORATORIES 4.72
MERCK & CO INC 4.27
THERMO FISHER SCIENTIFIC INC 3.65
MEDTRONIC PLC 3.44
Name Weight (%)
AMGEN INC 3.18
JOHNSON & JOHNSON 3.07
STRYKER CORPORATION 2.77
EDWARDS LIFESCIENCES CORP 2.72
ZOETIS INC 2.65

Exposure Breakdowns

Exposure Breakdowns

as of Dec 31, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Dec 31, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Dec 31, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Dec 31, 2019

% of Market Value Based on Managed Assets

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Kyle McClements
Kyle McClements
Christopher Accettella
Christopher Accettella
Portfolio Manager

Literature

Literature

Loading fund documents...
No documents found
Checkout {{ translations['submit'][selectedAction] }} {{ responseMessage }} {{ warningMessage }} You have previously requested to be opted out of all BlackRock Literature Services emails. To subscribe, you must opt back in.